meta_pixel
Tapesearch Logo
Log in
Science Quickly

Opioids Still Needed by Some Pain Patients

Science Quickly

Scientific American

Science

4.2639 Ratings

🗓️ 13 June 2017

⏱️ 3 minutes

🧾️ Download transcript

Summary

The "other victims" of the opioid epidemic are pain patients who need the drugs but cannot now get them because of fears related to their use   Learn more about your ad choices. Visit megaphone.fm/adchoices

Transcript

Click on a timestamp to play from that location

0:00.0

Understanding the human body is a team effort. That's where the Yachtel group comes in.

0:05.8

Researchers at Yachtolt have been delving into the secrets of probiotics for 90 years.

0:11.0

Yacold also partners with nature portfolio to advance gut microbiome science through the global grants for gut health, an investigator-led research program.

0:19.6

To learn more about Yachtolt, visit yawcult.co.

0:22.7

J-P. That's Y-A-K-U-L-T dot CO.J-P. When it comes to a guide for your gut, count on Yacolt.

0:33.4

This is Scientific Americans' 60-second science. I'm Steve Merski. The opioid epidemic is a national

0:41.1

crisis that should not be underestimated. That's a quote from a June 1st, New England Journal of

0:46.9

Medicine Perspective piece by Susan Glaude. She's a physician involved with hospice and palliative care

0:53.4

and pain management. But the title of

0:55.9

the piece reveals another issue related to the current situation. That title is the other

1:01.2

victims of the opioid epidemic, those other victims being people in desperate need of pain

1:07.3

treatment who cannot now get it because of fears related to the prescribing and use of opioids.

1:13.6

To try to help to avoid abuse, new forms of opioids have been created called abuse-deterrant opioid medications.

1:21.6

These can't be crushed or dissolved, thus making them difficult to snort or inject.

1:26.6

But these formulations would have no impact on other opioid-related deaths, such as unintentional overdose.

1:34.7

Glogd, in an audio interview related to her New England journal piece.

1:38.6

I think that the downside to all of these formulations are that they have the potential to make needed

1:45.6

medication more expensive and less accessible to patients who are having opioid responsive pain

1:51.1

and who really do require these medications.

1:53.9

What really worries me the most about all of this is that if the medical community,

1:59.3

the public, and policy makers get too distracted by the promise of a solution to the opioid epidemic in the guise of a reformulation of known opioids,

2:08.8

I'm worried that we're going to lose focus on addressing all of the underlying systemic issues that have really led to the epidemic in the first place,

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Scientific American, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Scientific American and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.